Clinical Decision Support Tool for Vancomycin Dosing in Children

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

April 12, 2024

Study Completion Date

May 10, 2025

Conditions
Gram-Positive Bacterial InfectionsVancomycinPharmacokineticsPharmacodynamics
Interventions
DEVICE

Computer Decision Support Tool Intervention Group

Computer Decision Support Tool using Bayesian estimation to dose IV vancomycin in pediatric patients using AUC24/MIC

OTHER

Matched Historical Controls

Vancomycin dosing based on standard hospital methods, with dose adjustments based on vancomycin trough targets

Trial Locations (1)

21201

University of Maryland Medical Center, Baltimore

All Listed Sponsors
collaborator

Center for Translational Medicine at the School of Pharmacy

UNKNOWN

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Maryland, Baltimore

OTHER